Skip to main content

Antibodies for Transplantation

  • Protocol
Diagnostic and Therapeutic Antibodies

Part of the book series: Methods in Molecular Medicine ((MIMM,volume 40))

Abstract

The use of antibodies in transplantation has become a clinical reality. Antibodies have been used to both dampen the recipient’s immune response and to obscure the immunogenicity of the donor graft. Traditionally, antibodies have been administered to the transplant recipient to transiently inactivate the host’s T cells, the lymphocytes responsible for recognizing and attacking foreign proteins, cells, and tissues. Antibodies can also be used to eliminate any highly immunogenic passenger cells from a donor graft prior to transplantation, and antibodies can mask or conceal antigens present on donor cells that might trigger rejection.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Köhler, G. and Milstein, C. (1975) Continuous culture of fused cells secreting antibody of predefined specificity. Nature256, 495–497.

    PubMed Central  Google Scholar 

  2. Medawar, P. B. (1957) The Uniqueness of the Individual, Basic Books, New York.

    Google Scholar 

  3. Russell, P. S. (1977) Antilymphocyte sera for immunosuppression, in Human Diagnosis and Therapy (Haber, E. and Krause, R., eds.), Raven, New York, pp. 303–355.

    Google Scholar 

  4. Anonymous (1985) A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants. Ortho Multicenter Transplant Study Group. New Engl. J. Med.313, 337–342.

    Google Scholar 

  5. Thurlow, P. J., Lovering, E., d’Apice, A. J., and McKenzie, I. F. (1983) A monoclonal antipan-T cell antibody: in vitro and in vivo studies. Transplantation36, 293–298.

    CAS  Google Scholar 

  6. Takahashi, H., Okazaki, H., Terasaki, P. I., Iwaki, Y., Kinukawa, T., Taguchi, Y., Chia, D., Hardiwidjaja, S., Miura, K., and Ishizaki, M. (1983) Reversal of transplant rejection by monoclonal antiblast antibody. Lancet2, 1155–1158.

    CAS  Google Scholar 

  7. Kirkman, R. L., Araujo, J. L., Busch, G. J., Carpenter, C. B., Milford, E. L., Reinherz, E. L., Schlossman, S. F., Strom, T. B., and Tilney, N. L. (1983) Treatment of acute renal allograft rejection with monoclonal anti-T12 antibody. Transplantation36, 620–626.

    CAS  Google Scholar 

  8. Kneteman, N. M., Marchetti, P., Tordjman, K., Bier, D. M., Santiago, J. V., Swanson, C. J., Olack, B. J., and Scharp D. W. (1992) Effects of cyclosporine on insulin secretion and insulin sensitivity in dogs with intrasplenic islet autotransplants. Surgery111, 430–437.

    CAS  Google Scholar 

  9. Metrakos, P., Hornby, L., and Rosenberg, L. (1993) Cyclosporine and islet massimplications for islet transplantation. J. Surg. Res.54, 375–380.

    CAS  Google Scholar 

  10. Hering, B. J., Browatzki, C. C., Schultz, A., Bretzel, R. G., and Federlin, K. F. (1993) Clinical islet transplantation-registry report, accomplishments in the past and future research needs. Cell Transplant.2, 269–282.

    CAS  Google Scholar 

  11. Jacobs, B. B. (1974) Ovarian allograft survival. Prolongation after passage in vitro. Transplantation18, 454–457.

    CAS  Google Scholar 

  12. Lafferty, K., Cooley, M., Woolnough, J., and Walker, K. (1975) Thyroid allograft immunogenicity is reduced after a period of organ culture. Science188, 259–261.

    CAS  Google Scholar 

  13. Lacy, P. E., Davie, J. M., and Finke, E. H. (1979) Prolongation of islet allograft survival following in vitro culture (24°C) and a single injection of ALS. Science204, 312,313.

    Google Scholar 

  14. Naji, A., Silvers, W. K., and Barker, C. F. (1979) Effect of culture in 95% O2 on the survival of parathyroid allografts. Surg. Forum30, 109–111.

    CAS  Google Scholar 

  15. Parr, E. L., Bowen, K. M., and Lafferty, K. J. (1980) Cellular changes in cultured mouse thyroid glands and islets of Langerhans. Transplantation30, 135–141.

    CAS  Google Scholar 

  16. Opelz, G. and Terasaki, P. I. (1974) Lymphocyte antigenicity loss with retention of responsiveness. Science184, 464–466.

    CAS  PubMed Central  Google Scholar 

  17. Parr, E. L. (1979) The absence of H-2 antigens from mouse pancreatic p-cells demonstrated by immunoferritin labeling. J. Exp. Med.150, 1–9.

    CAS  PubMed Central  Google Scholar 

  18. Faustman, D., Hauptfeld, V., Davie, J., Lacy, P., and Shreffler, D. (1980) Murine pancreatic β cells express H-2K and H-2D but not Ia antigens. J. Exp. Med.151, 1563–1569.

    CAS  Google Scholar 

  19. Baekkeskov, S., Kanatsuna, T., Klareskog, L., Nielsen, D. A., Peterson, P. A., Rubenstein, A. H., Steiner, D. F., and Lernmark, A. (1981) Expression of major histocompatibility antigens on pancreatic islet cells. Proc. Natl. Acad. Sci. USA78, 6456–6460.

    CAS  PubMed Central  Google Scholar 

  20. Faustman, D., Hauptfeld, V., Lacy, P., and Davie, J. (1981) Prolongation of murine islet allograft survival by pretreatment of islets with antibody directed to Ia determinants. Proc. Natl. Acad. Sci. USA78, 5156–5159.

    CAS  Google Scholar 

  21. Lechler, R. I. and Batchelor, J. R. (1982) Restoration of immunogenecity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J. Exp. Med.155, 31–41.

    CAS  Google Scholar 

  22. Hart, D. N. and Fabre, J. W. (1981) Demonstration and characterization of Ia-positive dendritic cells in the interstitial connective tissue of rat heart and other tissues, but not brain. J. Exp. Med.154, 347–361.

    CAS  Google Scholar 

  23. Faustman, D., Steinman, R., Gebel, H., Hauptfeld, V., Davie, J., and Lacy, P. (1984) Prevention of rejection of murine islet allografts by pre-treatment with anti-dendritic cell antibody. Proc. Natl. Acad. Sci. USA81, 3864–3868.

    CAS  Google Scholar 

  24. Sone, Y., Sakagami, K., and Orita, K. (1987) Effect of ex vivo perfusion with anti-IA monoclonal antibodies on rat cardiac allograft survival. Transplant. Proc.19, 599–604.

    CAS  Google Scholar 

  25. Lloyd, M., Buckingham, M., Stuart, F., and Thistlethwaite, J. R. (1989) Does depletion of donor dendritic cells an allograft lead to prolongation of graft survival in transplantation? Transplant. Proc.21, 482–483.

    CAS  Google Scholar 

  26. Otsubo, O., Sakai, A., Watanabe, T., and Inoi, T. (1983) Effect of anti-mouse Ia monoclonal antibody on canine renal allograft survival. Transplant. Proc.15, 797–799.

    Google Scholar 

  27. Brewer, Y., Palmer, A., Taube, D., Welsh, K., Bewick, M., Bindon, C., Hale, G., Waldmann, H., Dische, F., Parsons, V., and Snowden, S. (1989) Effect of graft perfusion with two CD45 monoclonal antibodies on incidence of kidney allograft rejection. Lancet2, 935–937.

    CAS  Google Scholar 

  28. Spits, H., van Schooten, W., Keizer, H., van Seventer, G., van de Rijn, M., Terhorst, C., and de Vries, J. E. (1986) Alloantigen recognition is preceded by nonspecific adhesion of cytotoxic T cells and target cells. Science232, 403–405.

    CAS  Google Scholar 

  29. Faustman, D. and Coe, C. (1991) Prevention of xenograft rejection by masking donor HLA class I antigens. Science252, 1700–1702.

    CAS  Google Scholar 

  30. Wu, J., Menapace, L., Barisoni, D., and Armato, U. (1992) An anti-beta-2-microglobulin monoclonal antibody prevents the reactive proliferation of lym-phocytes elicited by allo-human epidermal cells. J. Immunol. Res.4, 21–25.

    Google Scholar 

  31. Isobe, M., Yagita, H., Okumura, K., and Ihara, A. (1992) Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science255, 1125–1127.

    CAS  Google Scholar 

  32. Koller, B. H. and Smithies, O. (1989) Inactivating the beta-2 microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc. Natl. Acad. Sci. USA86, 8932–8935.

    CAS  Google Scholar 

  33. Zijlstra, M., Bix, M., Simister, N. E., Loring, J. M., Raulet, D. H., and Jaenisch, R. (1990) Beta 2-microglobulin-deficient mice lack CD4-8+cytolytic T cells. Nature344, 742–746.

    CAS  Google Scholar 

  34. Markmann, J. F., Bassiri, H., Desai, N. M., Odorico, J. S., Kim, J. I., Koller, B. H., Smithies, O., and Barker, C. F. (1992) Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. Transplantation54, 1085–1089.

    CAS  Google Scholar 

  35. Coffman, T., Geier, S., Ibrahim, S., Griffiths, R., Spurney, R., Smithies, O., Koller, B., and Sanfilippo, F. (1993) Improved renal function in mouse kidney allografts lacking MHC class I antigens. J. Immunol.151, 425–435.

    CAS  Google Scholar 

  36. Li, X. and Faustman, D. (1993) Use of donor 32-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts. Transplantation55, 940–946.

    CAS  Google Scholar 

  37. Zijlstra, M., Auchincloss, H., Loring, J. M., Chase, C. M., Russell, P. S., and Jaenisch, R. (1992) Skin graft rejection by beta 2-microglobulin-deficient mice. J. Exp. Med.175, 885–893.

    CAS  Google Scholar 

  38. Markmann, J. F., Jacobson, J. D., Kiumura, H., Choti, M. A., Hickey, W. F., Fox, I. J., Silvers, W. K., Barker, C. F., and Naji, A. (1989) Modulation of the major histocompatibility complex antigen and the immunogenicity of islet allografts. Transplantation48, 478–486.

    CAS  Google Scholar 

  39. Barker, C. F., Markmann, J. F., Posselt, A. M., and Naji, A. (1991) Studies of privileged sites and islet transplantation. Transplant. Proc.23, 2138–2142.

    CAS  Google Scholar 

  40. Doherty, P. C., Knowles, B. B., and Wettstein, P. J. (1984) Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T-cell function. Adv. Cancer Res.42, 1–65.

    CAS  Google Scholar 

  41. Hui, K., Grosveld, F., and Festenstein, H. (1984) Rejection of transplantable AKR leukaemia cells following MHC DNA-mediated cell transformation. Nature311, 750–752.

    CAS  Google Scholar 

  42. Rees, R. C., Buckle, A. M., Gelsthorpe, K., James, V., Potter, C. W., Rogers, K., and Jacob, G. (1988) Loss of polymorphic A and B locus HLA antigens in colon carcinoma. Br. J. Cancer57, 374–377.

    CAS  PubMed Central  Google Scholar 

  43. Karre, K., Ljunggren, H. G., Piontek, G., and Kiessling, R. (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature319, 675–678.

    CAS  Google Scholar 

  44. Smith, M. E., Marsh, S. G., Bodmer, J. G., Glesthorpe, K., and Bodmer, W. F. (1989) Loss of HLA-A,B,C allele products and lymphocyte function-associated antigen 3 in colorectal neoplasia. Proc. Natl. Acad. Sci. USA86, 5557–5561.

    CAS  Google Scholar 

  45. Manson, L. A. (1991) Does antibody-dependent epitope masking permit progressive tumour growth in the face of cell-mediated cytotoxicity? Immunol. Today12, 352–355.

    CAS  Google Scholar 

  46. Osorio, R. W., Ascher, N. L., Jaenisch, R., Freise, C. E., Roberts, J. P., and Stock, P. G. (1993) Major histocompatibility complex class I deficiency prolongs islet allograft survival. Diabetes42, 1520–1527.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Humana Press Inc.

About this protocol

Cite this protocol

Faustman, D.L. (2000). Antibodies for Transplantation. In: George, A.J.T., Urch, C.E. (eds) Diagnostic and Therapeutic Antibodies. Methods in Molecular Medicine, vol 40. Humana, Totowa, NJ. https://doi.org/10.1385/1-59259-076-4:141

Download citation

  • DOI: https://doi.org/10.1385/1-59259-076-4:141

  • Publisher Name: Humana, Totowa, NJ

  • Print ISBN: 978-0-89603-798-4

  • Online ISBN: 978-1-59259-076-6

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics